Cognitive and personality features in parkinson disease: 2 Sides of the same coin?

Cognitive and Behavioral Neurology

Volumn 22, Issue 4, 2009, Pages 258-263

  Volpato, Chiara ^a   Signorini, Matteo ^b,c   Meneghello, Francesca ^a   Semenza, Carlo ^a,d  

^a IRCCS SAN CAMILLO HOSPITAL   (Italy)

^b AFaR San Raffaele Arcangelo Fatebenefratelli Hospital   (Ethiopia)

^c CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Executive functions; Parkinson disease; Personality

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; AGED; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; EMOTIONAL STABILITY; FEMALE; HUMAN; INFORMATION PROCESSING; INTROVERSION; MALE; MOTIVATION; PARKINSON DISEASE; PERSEVERATION; PERSONAL EXPERIENCE; PERSONALITY; PERSONALITY DISORDER; PERSONALITY TEST; PLANNING; PRIORITY JOURNAL; PROBLEM SOLVING; TASK PERFORMANCE; WORKING MEMORY; AFFECT; EXECUTIVE FUNCTION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS;

ADULT; AFFECT; AGED; COGNITION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PERSONALITY; PERSONALITY ASSESSMENT; REGRESSION ANALYSIS;

EID: 73949137807     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNN.0b013e3181c12c63     Document Type: Article

References (56)

1. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain. 1992;115:1727-1751.
2. Downes JJ, Sharp HM, Costall BM, et al. Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment. Brain. 1993;116:887-902.
3. Dubois B, Pillon BJ. Cognitive deficits in Parkinson's disease. Neurol. 1997;244:2-8.
4. Cools R, Barker RA, Sahakian BJ, et al. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain. 2001;124:2503-2512.
5. Lewis SJ, Cools R, Robbins TW, et al. Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease. Neuropsychologia. 2003;41:645-654.
6. Ishihara L, Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord. 2006;21:1066-1072.
7. Evans AH, Lawrence AD, Potts J, et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006;77:317-321.
8. Mendelsohn GA, Dakof GA, Skaff M. Personality change in Parkinson's disease patients: chronic disease and aging. J Pers. 1995;63:233-257.
9. Glosser G, Clark C, Freundlich B, et al. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord. 1995;10:201-206.
10. Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study. Mov Disord. 1992;7:339-344.
11. Menza MA, Forman NE, Goldstein HS, et al. Parkinson's disease, personality, and dopamine. J Neuropsychiatry Clin Neurosci. 1990;2: 282-287.
12. Menza MA, Golbe LI, Cody RA, et al. Dopamine-related personality traits in Parkinson's disease. Neurology. 1993;43:505-508.
13. Menza MA, Mark MH. Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci. 1994;6:165-169.
14. MenzaMA, MarkMH, Burn DJ, et al. Personality correlates of [18F] dopa striatal uptake: results of positron-emission tomography in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1995;7:176-179.
15. Paulson GW, Dadmehr N. Is there a premorbid personality typical for Parkinson's disease? Neurology. 1991;41:73-76.
16. Kaasinen V, Nurmi E, Bergman J, et al. Personality traits and brain dopaminergic function in Parkinson's disease. Proc Natl Acad Sci USA. 2001;98:13272-13277.
17. Jacobs H, Heberlein I, Vieregge A, et al. Personality traits in young patients with Parkinson's disease. Acta Neurol Scand. 2001;103:82-87.
18. Pillon B, Czernecki V, Dubois B. Dopamine and cognitive function. Curr Opin Neurol. 2003;16:S17-S22.
19. Tomer R, Aharon-Peretz J. Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency. J Neurol Neurosurg Psychiatry. 2004;75:972-975.
20. Isella V, Melzi P, Grimaldi M, et al. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord. 2002;17:366-371.
21. Zgaljardic DJ, Borod JC, Foldi NS, et al. Relationship between selfreported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol. 2007;20:184-192.
22. Silberman CD, Laks J, Capitão CF, et al. Frontal functions in depressed and nondepressed Parkinson's disease patients: impact of severity stages. Psychiatry Res. 2007;149:285-289.
23. Klepac N, Trkulja V, Relja M. Nondemented Parkinson disease patients: is cognitive performance associated with depressive difficulties? Cogn Behav Neurol. 2008;21:87-91.
24. McNamara P, Durso R, Brown A. Relation of "Sense Of Self" to executive function performance in Parkinson's disease. Cogn Behav Neurol. 2003;16:139-148.
25. McNamara P, Durso R, Harris E. Alterations of the sense of self and personality in Parkinson's disease. Int J Geriatr Psychiatry. 2008;23:79-84.
26. Digman JM. Personality structure: emergence of the five-factor model. Ann Rev Psychol. 1990;41:417-440.
27. Caprara GV, Barbaranelli C, Steca P. Big Five Adjective. Firenze, Italy: Organizzazioni Speciali Press; 2002.
28. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. JNNP. 1992;55:181-184.
29. Fahn S, Elton R. Committee atmotUPsDRSD C. In: Fahn S, Mardsen C, Calne D, eds. Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's Disease. New York: MacMillan Press; 1987:153-163.
30. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
31. Spielberger CD, Gorsuch RL, Lushene RD. Manual of State-Trait Anxiety Inventory. Palo Alto, California: Consulting Psychologist Press; 1970.
32. Beck AT, Ward CH, Mendelsohn M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
33. Magni E, Binetti G, Bianchetti A, et al. Mini-mental state examination: a normative study in Italian elderly population. Eur J Neurol. 1996;3:1-5.
34. Brazzelli M, Capitani E, Della Sala S, et al. Neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan Overall Dementia Assessment. J Neurol Neurosurg Psychiatry. 1994;57:1510-1517.
35. Shallice T. Specific impairments of planning. Philos Transac Royal Soc Lond B. 1982;298:199-209.
36. Imamura A, Geda YE, Slowinskia J, et al. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol. 2008;15: 350-354.
37. Hubble JP, Venkatesh R, Hassanein RE, et al. Personality and depression in Parkinson's disease. J Nerv Ment Dis. 1993;181:657-662.
38. Harbishettar V, Pal PK, Janardhan Reddy YC, et al. Is there a relationship between Parkinson's disease and obsessive-compulsive disorder? Parkinsonism Relat Disord. 2005;11:85-88.
39. Lemke MR. Depressive symptoms in Parkinson's disease. Eur J Neurol. 2008;15:21-25.
40. Hughes C, Kumari V, Soni Q, et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res. 2002;123:243-255.
41. Gold JM, Carpenter C, Randolph C, et al. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry. 1997;54:159-165.
42. Perry W, Braff DL. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry. 1994;151:363-367.
43. Saykin AJ, Gur RC, Gur R, et al. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry. 1991;48:618-624.
44. Ferrier IN, Stanton BR, Kelly TP, et al. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry. 1999;175: 246-251.
45. Clark LD, Iversen SD, Goodwin G. Sustained attention deficit in bipolar disorder. Br J Psychiatry. 2002;180:313-319.
46. Van Gorp WG, Altshuler L, Theberge DC, et al. Declarative and procedural memory in bipolar disorder. Biol Psychiatry. 1999;46: 525-531.
47. Muller WR. Psychological deficit in depression. Psychol Bull. 1975; 82:238-260.
48. Elliot R, Baker SC, Rogers RD, et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med. 1997;27:931-942.
49. Deckersbach T, Savage CR, Curran T, et al. A study of parallel implicit and explicit information processing in obsessive- compulsive disorder. Am J Psychiatry. 2002;159:1780-1782.
50. Christensen KJ, Kim SW, Dysken MW, et al. Neuropsychological performance in obsessive-compulsive disorder. Biol Psychiatry. 1992;31:4-18.
51. O'Leary KM, Brouwers P, Gardner DL. Neuropsychological testing of patients with borderline personality disorder. Am J Psychiatry. 1991;148:106-111.
52. Bazanis E, Rogers RD, Dowson P. Neurocognitive deficits in decision-making and planning of patients with DSM-III-R borderline personality disorder. Psychol Med. 2002;32:1395-1405.
53. Fossati P, Coyette F, Ergis AM, et al. Influence of age and executive functioning on verbal memory of inpatients with depression. J Affect Disord. 2002;68:261-271.
54. Voon V, Hassan K, Zurowski M, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology. 2006;66:1750-1752.
55. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006;21:524-529.
56. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63:969-973.